In the News

Aardvark Therapeutics has been featured in numerous online resources and media sites.

Series C financing led by Decheng Capital and supported by a syndicate of new and existing investors including Cormorant Asset...
The FDA granted Aardvark Therapeutics a Rare Pediatric Designation for the use of ARD-101 in Prader-Willi Syndrome (PWS), a rare...

To view the full article, click here (external link)

...